Old Web
English
Sign In
Acemap
>
authorDetail
>
Srinivas Shankara
Srinivas Shankara
Sanofi S.A.
Medicine
Internal medicine
Alemtuzumab
Neurofilament
Oncology
4
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samples
2021
medRxiv
Virginia Savova
Richa Hanamsagar
Mathew Chamberlain
Srinivas Shankara
Robert Marcus
Darren P. Baker
Klinger Kw
Evis Havari
Frank Nestle
Emanuele de Rinaldis
Show All
Source
Cite
Save
Citations (0)
Network Analysis and Human Single Cell Brain Transcriptomics Reveal Novel Aspects of Alpha-Synuclein (SNCA) Biology
2020
bioRxiv
Erin Teeple
Khushboo Jindal
Beril Kiragasi
Siddharth Annaldasula
Ann Byrne
Lily Chai
Mahdiar Sadeghi
Can Kayatekin
Srinivas Shankara
Katherine Klinger
S. Pablo Sardi
Stephen L. Madden
Dinesh Kumar
Show All
Source
Cite
Save
Citations (3)
Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson's Disease Risk
2020
medRxiv
Yingnan Han
Erin Teeple
Srinivas Shankara
Mahdiar Sadeghi
Cheng Zhu
Dongyu Liu
FinnGen
Clarence Wang
Francesca Frau
Katherine W. Klinger
Stephen L. Madden
Deepak Rajpal
S. Pablo Sardi
Dinesh Kumar
Show All
Source
Cite
Save
Citations (3)
Alemtuzumab Treatment Reduces Serum Neurofilament to Levels Comparable With Healthy Controls More Effectively Than SC IFNb-1a: CARE-MS I
2019
Evis Havari
Nadia Daizadeh
Christian Barro
Zuzanna Michalak
David Leppert
Jean Godin
Srinivas Shankara
Luke Chung
Nora Roesch
Carina Kaiser
Tarek A Samad
Alan Jacobs
Ludwig Kappos
Jens Kuhle
Show All
Source
Cite
Save
Citations (0)
1